W Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
W Advisors's ABBV Position: Q3 2026 in Review
W Advisors increased its AbbVie (ABBV) stake by 3% in Q3 2026, buying an estimated $20.3K and bringing the position to 2,727 shares worth $713K. The position accounts for 0.31% of the portfolio, ranked #70.
W Advisors first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. 3,876 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- W Advisors held 2,727 shares of AbbVie worth $713K as of Q3 2026.
- W Advisors bought 79 AbbVie shares in Q3 2026, an estimated $20.3K.
- AbbVie made up 0.31% of W Advisors's portfolio in Q3 2026, its #70 holding.
- W Advisors first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
- 3,876 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on W Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.